GGrantIndex
Sort

48,018 grants matching immunotherapy

Targeting Negative Regulatory Pathways for Immunotherapy of B-Cell Lymphomas

$453,876
Eduardo M Sotomayor · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2012 · CA

Epigenetic Therapy for Thoracic Malignancies

$453,874
David Schrump · Division Of Clinical Sciences - Nci · ZIA · FY2018 · CA

Matrix assembly and remodeling during S. aureus biofilm development

$453,759
Kenneth W. Bayles · University Of Nebraska Medical Center · P01 · FY2017 · AI

Inhibitory Pathways Underlying Viral Persistance in vivo

$453,754
Elina I Zuniga · University Of California, San Diego · R01 · FY2012 · AI

Genomics and Computational Biology Shared Resource

$453,745
Kelly A Frazer · University Of California, San Diego · P30 · FY2022 · CA

Improving Patient Adherence to Cancer Treatment

$453,703
University Of Southern California · R01 · FY2004 · CA

Metastatic Clonal Heterogeneity and its Impact on Melanoma Therapeutic Resistance

$453,702
Willy Hugo · University Of California Los Angeles · R01 · FY2023 · CA

Programming of CD8+ T Cell Tolerance by B Cell APC

$453,692
Stephen Philip Schoenberger · La Jolla Institute For Immunology · R01 · FY2010 · AI

Cancer Genomics and Epigenomics

$453,662
Jean Gautier · Columbia University Health Sciences · P30 · FY2025 · CA

Tumor Biology and Microenvironment Program

$453,662
Michael M. Shen · Columbia University Health Sciences · P30 · FY2025 · CA

Combating Breast Cancer Brain Metastasis by Blocking the Two-Pronged Driver Kinase Function of CDK5

$453,646
Dihua Yu · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA

Combating Breast Cancer Brain Metastasis by Blocking the Two-Pronged Driver Kinase Function of CDK5

$453,646
Dihua Yu · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA

Combating Breast Cancer Brain Metastasis by Blocking the Two-Pronged Driver Kinase Function of CDK5

$453,646
Dihua Yu · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA

A Novel Target in The Tumor Myeloid Compartment for Hepatocellular Carcinoma

$453,620
Xiang-Yang Wang · Virginia Commonwealth University · P01 · FY2025 · CA

A Novel Target in The Tumor Myeloid Compartment for Hepatocellular Carcinoma

$453,620
Xiang-Yang Wang · Virginia Commonwealth University · P01 · FY2024 · CA

Project 3 - Zuniga

$453,606
Elina I Zuniga · University Of California, San Diego · P01 · FY2022 · AI

Modulation of repopulation of anti HIV-1 gene-modified cells to enhance efficacy and safety

$453,562
Dong Sung An · University Of California Los Angeles · U19 · FY2023 · AI

Targeting Post-Transplant Minimal Residual CD19+ ALL with Genetically-

$453,508
Laurence J.n. Cooper · Beckman Research Institute/City Of Hope · P01 · FY2007 · CA

Targeting Focal Adhesion Kinase to Improve RT-inducted Tumor Immunity

$453,504
David G Denardo · Washington University · R01 · FY2020 · CA

Epigenetic Regulation of Head and Neck Cancer Immune Evasion

$453,476
Chao Lu · Columbia University Health Sciences · R01 · FY2023 · DE

Epigenetic Regulation of Head and Neck Cancer Immune Evasion

$453,476
Chao Lu · Columbia University Health Sciences · R01 · FY2025 · DE

Roles of Coactivator-Associated Arginine Methyltransferase 1 in B cell activation and lymphomagenesis

$453,454
Michael Richard Green · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA

Roles of Coactivator-Associated Arginine Methyltransferase 1 in B cell activation and lymphomagenesis

$453,454
Margarida Santos · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA

Microfluidic sorting of lung cancer cells from leukapheresis product as an alternative to metastatic tumor biopsy

$453,440
Mehmet Toner · Massachusetts General Hospital · R01 · FY2025 · CA

Mutational signature analysis: methods and applications to the clinic

$453,411
Peter Park · Harvard Medical School · R01 · FY2025 · CA